Literature DB >> 6901611

In vivo monoamine oxidase inhibition by d-amphetamine.

H H Miller, P A Shore, D E Clarke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6901611     DOI: 10.1016/0006-2952(80)90429-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  23 in total

1.  Methamphetamine reward in mice as assessed by conditioned place preference test with Supermex sensors: effect of subchronic clorgyline pretreatment.

Authors:  Nobue Kitanaka; Junichi Kitanaka; Tomohiro Tatsuta; Kaname Watabe; Yoshio Morita; Motohiko Takemura
Journal:  Neurochem Res       Date:  2006-06-22       Impact factor: 3.996

Review 2.  Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

Authors:  M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 3.  The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.

Authors:  Stephen V Faraone
Journal:  Neurosci Biobehav Rev       Date:  2018-02-08       Impact factor: 8.989

Review 4.  Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.

Authors:  S R Jones; R R Gainetdinov; R M Wightman; M G Caron
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

5.  Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo.

Authors:  Eric S Ramsson; Daniel P Covey; David P Daberkow; Melissa T Litherland; Steven A Juliano; Paul A Garris
Journal:  J Neurochem       Date:  2011-05-03       Impact factor: 5.372

Review 6.  Kinetics, mechanism, and inhibition of monoamine oxidase.

Authors:  Rona R Ramsay; Alen Albreht
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

Review 7.  CNS-targeting pharmacological interventions for the metabolic syndrome.

Authors:  Kerstin Stemmer; Timo D Müller; Richard D DiMarchi; Paul T Pfluger; Matthias H Tschöp
Journal:  J Clin Invest       Date:  2019-08-05       Impact factor: 14.808

8.  Effects of antipsychotic drugs on the long-term effects of amphetamine on nigro-striatal dopamine neurons in iprindole-treated rats.

Authors:  L R Steranka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

9.  Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.

Authors:  V Glover; C J Pycock; M Sandler
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

10.  Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain.

Authors:  Abesh K Bhattacharjee; Lisa Chang; Mei Chen; Laura White; Jane M Bell; Richard P Bazinet; Stanley I Rapoport
Journal:  Int J Neuropsychopharmacol       Date:  2008-06-23       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.